Evidence map›Paper›PMID 37435055›Full record

ArticleFrontiers in cardiovascular medicine2023

Quality of life in patients with transcatheter aortic valve implantation: an analysis from the INTERVENT project.

Alexander R Tamm, Marina L Jobst, Martin Geyer, Omar Hahad, Victoria Buderus, Alexander Schmidt, Jürgen H Prochaska, Philipp S Wild, Hendrik Treede, Thomas Münzel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alexander R Tamm *Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Marina L Jobst *Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Martin GeyerDepartment of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Omar HahadDepartment of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Victoria BuderusDepartment of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Alexander SchmidtDepartment of Cardiology, Preventive Cardiology and Preventive Medicine, University Medical Center Mainz, Mainz, Germany.
Jürgen H ProchaskaDepartment of Cardiology, Preventive Cardiology and Preventive Medicine, University Medical Center Mainz, Mainz, Germany.
Philipp S WildDepartment of Cardiology, Preventive Cardiology and Preventive Medicine, University Medical Center Mainz, Mainz, Germany.
Hendrik TreedeDepartment of Cardio-Thoracic and Vascular Surgery, University Medical Center Mainz, Mainz, Germany.
Thomas MünzelDepartment of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Ralph Stephan von BardelebenDepartment of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is a standard treatment for patients with aortic valve stenosis due to its very low mortality and complication rates. However, survival and physical integrity are not the only important factors. Quality of life (QoL) improvement is a crucial part in the evaluation of therapy success. Methods: Patients with TAVI were questioned about their QoL before, one month and one year after the intervention as part of the INTERVENT registry trial at Mainz University Medical Center. Three different questionnaires were included in the data collection (Katz ADL, EQ-5D-5l, PHQ-D). Results: We included 285 TAVI patients in the analysis (mean age 79.8 years, 59.4% male, mean EuroSCORE II 3.8%). 30-day mortality was 3.6%, complications of any kind occurred in 18.9% of the patients. Main finding was a significant increase in the general state of health measured on the visual analog scale by an average of 4.53 (± 23.58) points (BL to 1-month follow-up, Conclusion: We could show an early benefit of QoL in TAVI patients with significant improvement in the subjective state of health and a decrease in symptoms of depression. These findings were consistent over 1 year of follow up.

Indexed as

aortic stenosis (AS)biobankingdepression—epidemiologyquality of lifeTAVI—transcatheter aortic valve implantation

Identifiers

PMID37435055
PMCPMC10330696
OpenAlexW4382136893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.